and medroxyprogesterone acetate (MPA), including depot formulations, which is effective but associated with bone mineral density loss with prolonged use
It also imitates a second hormone, called GIP, which along with reducing appetite, may also improve how the body breaks down sugar and fat
Therefore, not all headaches occurring during semaglutide therapy are necessarily caused by the medication
Christopher Elia, DO Physician, Co-Founder Note: GLP-1 medications can cause nausea, vomiting, delayed stomach emptying, andin rare casesserious complications, and should be used only with proper medical supervision This information is not FDA-reviewed, and the product is not intended for diagnosis, treatment, cure, or prevention of disease